Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT).

Publikation

Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT).

Wissenschaftlicher Artikel/Review - 12.12.2023

Verardi Fabio, Maul Lara Valeska, Borsky Kim, Steinmann Simona, Rosset Nina, Pons Hector Ortega, Sorbe Christina, Yawalkar Nikhil, Micheroli Raphael, Egeberg Alexander, Thyssen Jacob P, Heidemeyer Kristine, Boehncke Wolf-Henning, Conrad Curdin, Cozzio Antonio, Pinter Andreas, Kündig Thomas M, Navarini Alexander A, Maul Julia-Tatjana

Zitation

Verardi F, Maul L, Borsky K, Steinmann S, Rosset N, Pons H, Sorbe C, Yawalkar N, Micheroli R, Egeberg A, Thyssen J, Heidemeyer K, Boehncke W, Conrad C, Cozzio A, Pinter A, Kündig T, Navarini A, Maul J. Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT). J Eur Acad Dermatol Venereol 2023

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

J Eur Acad Dermatol Venereol 2023

Veröffentlichungsdatum

12.12.2023

eISSN (Online)

1468-3083

Kurzbeschreibung/Zielsetzung

Psoriasis is a disease that often requires prolonged systemic treatment. It is important to determine the safety of available therapies. There is currently little insight into sex-specific differences in the safety of systemic psoriasis therapies.